Abstract 003: Contextual- And Personal-level Social Determinants Of Health And Real-world Adoption Of Novel Treatments For Improving Cardiovascular Outcomes In Type 2 Diabetes

Jingchuan Guo,Hui Hu,Yi Zheng,Yi Guo,Aokun Chen,Jared W Magnani,Inmaculada Hernandez,LaToya O'Neal,Elizabeth Shenkman,Jiang Bian

DOI: https://doi.org/10.1161/circ.145.suppl_1.003

IF: 37.8

2022-03-01

Circulation

Abstract:Background: The two novel antidiabetic drugs ( ADD ), sodium-glucose cotransporter-2 inhibitors ( SGLT2i ) and glucagon-like peptide-1 receptor agonists ( GLP1a ), have shown distinctive cardiovascular benefits. However, prior studies have found racial disparities in the initiation of SGLT2i/GLP1a, suggesting that, despite their potential, the real-world utilization of these therapies may exacerbate health inequities. Our study was aimed to understand how contextual and personal-level social determinants of health ( SDoH ) interact and drive inequities in access to these novel agents. Methods: Using electronic health records ( EHR ) from the University of Florida Health system, we assembled a cohort of type 2 diabetes ( T2D ) who initiated a second line ADD in 2015-2020. The T2D cohort was spatiotemporally linked to a set of 79 contextual SDoH documenting social and built environment at census tract level. Normalization transformation was conducted for these variables, as needed. We applied an exposome-wide association study ( ExWAS ) approach to identify key contextual SDoH associated with SGTL2i/GLP1a initiation vs. other second line ADD. We identified patients’ marital status, as proxy of social support, among other personal-level SDoH from clinical notes via a natural language processing pipeline. We applied logistic regression and adjusted for clinical factors to determine the effect of contextual SDoH on SGLT2i/GLP1a initiation across racial groups and by personal-level SDoH. Results: Of 2,563 study patients, 57% were females, 42% were Blacks, and the mean age was 59 (13) years. We identified three contextual SDoH factors that were statistically significantly associated with lower likelihood of SGLT2i/GLP1a initiation: neighborhoods with limited food access, with more long-term vacant houses, and with less group quarters (e.g., living in nursing facilities and group homes). In the subgroup analysis by race, neighborhoods with limited food access ( p =.025) and having less group quarter ( p =.028) are barriers to initiate newer ADD only in White patients, while living in neighborhoods having more vacant houses was a risk factor of the newer drug initiation only in Black patients ( p <.001). When subgrouped by marital status, living in a place with less group quarters was a risk factor of non-initiation of SGLT2i/GLP1a only in those being unmarried ( p =.027), while living in a place having more vacant addresses was a risk factor of non-initiation only in those being married ( p <.001). Conclusion: We identified novel contextual SDoH associated with lower initiation of novel cardioprotective drugs in patients with T2D. The effect of contextual SDOH in such treatment initiation varies across racial groups and by marital status.

cardiac & cardiovascular systems,peripheral vascular disease